Published in Mol Med Today on February 01, 1999
The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms. Nucleic Acids Res (2001) 3.45
Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience (2007) 2.55
Shining a light on xeroderma pigmentosum. J Invest Dermatol (2012) 2.33
Structural basis for recruitment of translesion DNA polymerase Pol IV/DinB to the beta-clamp. EMBO J (2003) 2.25
Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J Exp Med (2010) 1.86
The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J (2006) 1.73
Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. J Invest Dermatol (2009) 1.64
Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin. EMBO J (2003) 1.59
The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res (2002) 1.58
Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol (2008) 1.46
Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc Natl Acad Sci U S A (2007) 1.43
Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations. Mol Cell Biol (2005) 1.32
Nucleotide excision repair and cancer. J Mol Histol (2006) 1.27
Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci U S A (2004) 1.26
The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. Proc Natl Acad Sci U S A (2000) 1.25
TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol (2005) 1.23
DNA repair phenotype and cancer susceptibility--a mini review. Int J Cancer (2009) 1.15
Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients. J Exp Med (2009) 0.99
DNA repair diseases: What do they tell us about cancer and aging? Genet Mol Biol (2014) 0.98
XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest (2010) 0.92
The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair. DNA Repair (Amst) (2009) 0.87
Construction and purification of site-specifically modified DNA templates for transcription assays. Nucleic Acids Res (2003) 0.85
Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck. PLoS One (2012) 0.85
Hydrogen peroxide induced genomic instability in nucleotide excision repair-deficient lymphoblastoid cells. Genome Integr (2010) 0.85
XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Biochim Biophys Acta (2010) 0.85
Post-transcriptional regulation of DNA damage-responsive gene expression. Antioxid Redox Signal (2013) 0.83
The nucleosome-binding protein HMGN2 modulates global genome repair. FEBS J (2009) 0.82
The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin. J Dermatol Sci (2009) 0.81
Telomere attrition and genomic instability in xeroderma pigmentosum type-b deficient fibroblasts under oxidative stress. J Cell Mol Med (2009) 0.81
Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew. Arch Dermatol (2009) 0.80
In vitro functional effects of XPC gene rare variants from bladder cancer patients. Carcinogenesis (2011) 0.80
Role of Oxidative RNA Damage in Chronic-Degenerative Diseases. Oxid Med Cell Longev (2015) 0.79
Does melanoma begin in a melanocyte stem cell? J Skin Cancer (2012) 0.79
Gene expression profiling of xeroderma pigmentosum. Hered Cancer Clin Pract (2006) 0.78
Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis. Photochem Photobiol (2014) 0.75
Xeroderma pigmentosum: clinicopathological review of the multiple oculocutaneous malignancies and complications. Indian J Surg Oncol (2014) 0.75
Human polyomaviruses and incidence of cutaneous squamous cell carcinoma in the New Hampshire skin cancer study. Cancer Med (2016) 0.75
Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol (1987) 5.88
Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med (1974) 5.16
DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol (2001) 4.00
The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms. Nucleic Acids Res (2001) 3.45
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
Photoproduct frequency is not the major determinant of UV base substitution hot spots or cold spots in human cells. Proc Natl Acad Sci U S A (1987) 2.50
DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis (1984) 2.35
Genetic heterogeneity in xeroderma pigmentosum: complementation groups and their relationship to DNA repair rates. Proc Natl Acad Sci U S A (1975) 2.29
Cockayne syndrome and xeroderma pigmentosum. Neurology (2000) 2.24
Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair. Nat Med (2001) 2.04
Restricted ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum cells. Proc Natl Acad Sci U S A (1986) 1.92
Five complementation groups in xeroderma pigmentosum. Mutat Res (1975) 1.91
Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet (2008) 1.85
One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc Natl Acad Sci U S A (1985) 1.81
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Ultraviolet hypermutability of a shuttle vector propagated in xeroderma pigmentosum variant cells. J Invest Dermatol (1993) 1.67
Multiple point mutations in a shuttle vector propagated in human cells: evidence for an error-prone DNA polymerase activity. Proc Natl Acad Sci U S A (1987) 1.66
The dysplastic nevus syndrome: our definition. Am J Dermatopathol (1982) 1.63
Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. J Am Acad Dermatol (1997) 1.56
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
Clearing of melanoma in situ with intralesional interferon alfa in a patient with xeroderma pigmentosum. Arch Dermatol (1994) 1.46
UV light-induced cyclobutane pyrimidine dimers are mutagenic in mammalian cells. Mol Cell Biol (1986) 1.41
Site-specific oxidative DNA damage at polyguanosines produced by copper plus hydrogen peroxide. J Biol Chem (1989) 1.37
Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet (2001) 1.33
Xeroderma pigmentosum--bridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed (2001) 1.28
The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat Res (1996) 1.26
The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. Proc Natl Acad Sci U S A (2000) 1.25
A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis (2000) 1.21
An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res (2001) 1.21
DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells. J Invest Dermatol (1996) 1.20
Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res (1992) 1.19
Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development. Clin Genet (2009) 1.18
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. J Invest Dermatol (1998) 1.11
Xeroderma pigmentosum. Clin Dermatol (1986) 1.08
A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. J Invest Dermatol (2001) 1.08
Reduced repair of non-dimer photoproducts in a gene transfected into xeroderma pigmentosum cells. Photochem Photobiol (1986) 1.07
Joining of linear plasmid DNA is reduced and error-prone in Bloom's syndrome cells. EMBO J (1989) 1.06
Heritable genetic alterations in a xeroderma pigmentosum group G/Cockayne syndrome pedigree. Mutat Res (1997) 1.02
Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids. Carcinogenesis (1995) 1.02
Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life. J Invest Dermatol (2000) 1.02
Quantification of expression of linked cloned genes in a simian virus 40-transformed xeroderma pigmentosum cell line. Mol Cell Biol (1985) 1.01
Dysplastic naevi and cutaneous melanoma risk. Lancet (1983) 0.99
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr (1983) 0.98
Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy. J Cutan Med Surg (1998) 0.98
Detection of ataxia telangiectasia heterozygous cell lines by postirradiation cumulative labeling index: measurements with coded samples. Cancer Res (1987) 0.97
Repair of DNA in xeroderma pigmentosum conjunctiva. Arch Ophthalmol (1975) 0.95
Evidence for defective repair of cyclobutane pyrimidine dimers with normal repair of other DNA photoproducts in a transcriptionally active gene transfected into Cockayne syndrome cells. Mutat Res (1991) 0.95
Decreased thymidine incorporation in circulating leukocytes after treatment of psoriasis with psoralen and long-wave ultraviolet light. J Invest Dermatol (1977) 0.94
Topical immunotherapy of basal cell carcinomas with dinitrochlorobenzene. Cancer Res (1973) 0.93
Adult-onset xeroderma pigmentosum neurological disease--observations in an autopsy case. Clin Neuropathol (2002) 0.93
Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med (1986) 0.93
The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells. Cancer Res (1994) 0.93
Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F. Cancer Res (1991) 0.92
Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility. Cancer Res (1986) 0.92
Abnormal ultraviolet mutagenic spectrum in plasmid DNA replicated in cultured fibroblasts from a patient with the skin cancer-prone disease, xeroderma pigmentosum. J Clin Invest (1987) 0.91
Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma. J Am Acad Dermatol (1987) 0.91
Prolonged ultraviolet-induced thymidine incorporation into xeroderma pigmentosum lymphocytes: studies on its duration, amount, localization and relationship to hydroxyurea. Biochim Biophys Acta (1972) 0.91
An SV40-transformed xeroderma pigmentosum group D cell line: establishment, ultraviolet sensitivity, transfection efficiency and plasmid mutation induction. Mutat Res (1986) 0.90
Mutational hotspot variability in an ultraviolet-treated shuttle vector plasmid propagated in xeroderma pigmentosum and normal human lymphoblasts and fibroblasts. J Mol Biol (1990) 0.90
Ultraviolet-induced mutations in Cockayne syndrome cells are primarily caused by cyclobutane dimer photoproducts while repair of other photoproducts is normal. Proc Natl Acad Sci U S A (1993) 0.89
Ataxia-telangiectasis: a multisystem hereditary disease with immunodeficiency, impaired organ maturation, x-ray hypersensitivity, and a high incidence of neoplasia. Ann Intern Med (1983) 0.89
Influence of ataxia telangiectasia gene dosage on bleomycin-induced chromosome breakage and inhibition of replication in human lymphoblastoid cell lines. Exp Cell Res (1982) 0.88
Survival of human lymphoblastoid cells after DNA damage measured by growth in microtiter wells. Mutat Res (1980) 0.88
Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts. J Invest Dermatol (2001) 0.87
Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest (1993) 0.86
Ultraviolet mutagenesis in human lymphocytes: the effect of cellular transformation. Exp Cell Res (1992) 0.86
Xeroderma pigmentosum long-term lymphoid lines with increased ultraviolet sensitivity. J Natl Cancer Inst (1974) 0.85
Ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum lymphoblastoid cells and fibroblasts. Mutat Res (1991) 0.85
Hypoglycinaemia and psychomotor delay in a child with xeroderma pigmentosum. J Inherit Metab Dis (1999) 0.83
Abnormal processing of transfected plasmid DNA in cells from patients with ataxia telangiectasia. Mutat Res (1992) 0.83
Abnormal rate and duration of ultraviolet-induced thymidine incorporation into lymphocytes from patients with Xeroderma pigmentosum and associated neurological complications. Mutat Res (1972) 0.82
Host cell reactivation by human cells of DNA expression vectors damaged by ultraviolet radiation or by acid-heat treatment. Carcinogenesis (1986) 0.81
Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma. Dermatol Clin (1985) 0.80
Plasmid vectors for study of DNA repair and mutagenesis. Curr Probl Dermatol (1987) 0.80
Managing the dysplastic naevus syndrome. Lancet (1984) 0.80
Conformational differences in protein disulfide linkages between normal hair and hair from subjects with trichothiodystrophy: a quantitative analysis by Raman microspectroscopy. Biopolymers (2006) 0.80
Carrier detection in xeroderma pigmentosum. J Clin Invest (1990) 0.80
Ultraviolet mutagenesis in a plasmid vector replicated in lymphoid cells from patient with the melanoma-prone disorder dysplastic nevus syndrome. Cancer Res (1989) 0.79
In vitro assay of the effects of psoralens plus ultraviolet radiation on human lymphoid cells. J Natl Cancer Inst (1982) 0.79
DNA repair in tumor cells from the variant form of xeroderma pigmentosum. J Invest Dermatol (1975) 0.79
A potential laboratory test for dysplastic nevus syndrome: ultraviolet hypermutability of a shuttle vector plasmid. J Invest Dermatol (1994) 0.79
Effects of 8-methoxypsoralen and ultraviolet radiation on human lymphoid cells in vitro. J Invest Dermatol (1981) 0.78
Xeroderma pigmentosum. A prototype disease of environmental-genetic interaction. Arch Dermatol (1980) 0.78
Colony-forming ability of ultraviolet-irradiated xeroderma pigmentosum fibroblasts from different DNA repair complementation groups. Biochim Biophys Acta (1976) 0.78
In-vivo assessment of DNA ligation efficiency and fidelity in cells from patients with Fanconi's anemia and other cancer-prone hereditary disorders. Toxicol Lett (1993) 0.78
Psoralen plus ultraviolet radiation-induced inhibition of DNA synthesis and viability in human lymphoid cells in vitro. Photochem Photobiol (1979) 0.78
N-methyl-N-nitrosourea-induced mutations in a shuttle plasmid replicated in human cells. Mol Carcinog (1990) 0.77
Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes. Gene Ther (2004) 0.77
Retinoid protection against x-ray-induced chromatid damage in human peripheral blood lymphocytes. J Clin Invest (1992) 0.77
Hypermutability of UV-treated plasmids in dysplastic nevus/familial melanoma cell lines. Cancer Res (1997) 0.77
Complementing xeroderma pigmentosum fibroblasts restore biological activity to UV-damaged DNA. Mutat Res (1975) 0.77
DNA crosslinking and cell survival in human lymphoid cells treated with 8-methoxypsoralen and long wavelength ultraviolet radiation. Mutat Res (1981) 0.76
Isotretinoin does prevent skin cancer. Arch Dermatol (1993) 0.75
Alterations in leukocyte aryl hydrocarbon hydroxylase activity associated with treatment and age in psoriasis patients and healthy individuals. Arch Dermatol Res (1984) 0.75
Letter: Contact allergy to tylosin. Arch Dermatol (1976) 0.75
Early onset of skin and oral cavity neoplasms in xeroderma pigmentosum. Lancet (1982) 0.75
Xeroderma pigmentosum: a nursing perspective. Dermatol Nurs (1990) 0.75
Xeroderma pigmentosum knockout mice: an immunologic tale. J Invest Dermatol (1996) 0.75
Inhibition of mixed leukocyte culture reaction by 8-methoxypsoralen and long-wavelength ultraviolet radiation. J Invest Dermatol (1981) 0.75